Most not long ago, it's been recognized that conolidine and the above derivatives act over the atypical chemokine receptor three (ACKR3. Expressed in equivalent areas as classical opioid receptors, it binds to a wide array of endogenous opioids. Compared with most opioid receptors, this receptor acts for a scavenger and isn't going to activate a 2n